These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23260006)

  • 1. Thrombocytopenia following high-dose chemotherapy with carboplatin, etoposide and thiotepa in patients with testicular germ cell cancer.
    Minichmayr I; Nock V; Jaehde U; Kloft C
    Int J Clin Pharmacol Ther; 2013 Jan; 51(1):74-6. PubMed ID: 23260006
    [No Abstract]   [Full Text] [Related]  

  • 2. Lethal ischemic stroke after cisplatin-based chemotherapy for testicular carcinoma and cannabis inhalation.
    Russmann S; Winkler A; Lövblad KO; Stanga Z; Bassetti C
    Eur Neurol; 2002; 48(3):178-80. PubMed ID: 12373036
    [No Abstract]   [Full Text] [Related]  

  • 3. High-dose chemotherapy in nonseminomatous germ cell cancer.
    Kollmannsberger C; Beyer J; Bokemeyer C
    BJU Int; 2009 Nov; 104(9 Pt B):1398-403. PubMed ID: 19840020
    [No Abstract]   [Full Text] [Related]  

  • 4. High failure rate of carboplatin-etoposide combination in good risk non-seminomatous germ cell tumours.
    Kattan J; Mahjoubi M; Droz JP; Kramar A; Culine S; Boutan-Laroze A; Chazard M
    Eur J Cancer; 1993; 29A(11):1504-9. PubMed ID: 8217352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy.
    Bajorin DF; Motzer RJ; Rodriguez E; Murphy B; Bosl GJ
    J Natl Cancer Inst; 1993 Jan; 85(1):60-2. PubMed ID: 7677936
    [No Abstract]   [Full Text] [Related]  

  • 6. [Carboplatin-etoposide-bleomycine chemotherapy protocol in the treatment of patients with metastatic non-seminomatous germ-cell testicular tumours with good prognosis].
    Jeremić B; Djurić Lj; Djordjević S; Cirović V; Milojević Lj; Stanisavljević B; Matović M; Mijatović Lj
    Srp Arh Celok Lek; 1994; 122(9-10):257-9. PubMed ID: 17977429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study.
    Bajorin DF; Sarosdy MF; Pfister DG; Mazumdar M; Motzer RJ; Scher HI; Geller NL; Fair WR; Herr H; Sogani P
    J Clin Oncol; 1993 Apr; 11(4):598-606. PubMed ID: 8386751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin.
    Huitema AD; Spaander M; Mathĵt RA; Tibben MM; Holtkamp MJ; Beijnen JH; Rodenhuis S
    Ann Oncol; 2002 Mar; 13(3):374-84. PubMed ID: 11996467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of good risk germ-cell tumours.
    Troost MM; Sternberg CN; de Wit R
    BJU Int; 2009 Nov; 104(9 Pt B):1387-91. PubMed ID: 19840018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report.
    Sokolova A; Chan O; Ullah W; Hamdani AA; Anwer F
    J Med Case Rep; 2017 Apr; 11(1):100. PubMed ID: 28395668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The optimisation of carboplatin dose in carboplatin, etoposide and bleomycin combination chemotherapy for good prognosis metastatic nonseminomatous germ cell tumours of the testis.
    Childs WJ; Nicholls EJ; Horwich A
    Ann Oncol; 1992 Apr; 3(4):291-6. PubMed ID: 1382552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of multiple courses of high-dose cyclophosphamide, thiotepa, and carboplatin for breast cancer or germ cell cancer.
    Rodenhuis S; Westermann A; Holtkamp MJ; Nooijen WJ; Baars JW; van der Wall E; Slaper-Cortenbach IC; Schornagel JH
    J Clin Oncol; 1996 May; 14(5):1473-83. PubMed ID: 8622061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-CECaT: a breakthrough for patients with neuroblastoma.
    Donfrancesco A; Deb G; Angioni A; Maurizio C; Cozza R; Jenkner A; Landolfo A; Boglino C; Helson L
    Anticancer Drugs; 1993 Jun; 4(3):317-21. PubMed ID: 8395258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial with etoposide (VP16) plus ifosfamide plus high-dose cisplatin (VIhP regimen) in refractory germ cell tumors.
    Droz JP; Ribrag V; Ghosn M; Guimares J; Theodore C; Azab M; Ostronoff M; Mahjoubi M; Moran A; Pico J
    Prog Clin Biol Res; 1989; 303():739-47. PubMed ID: 2550949
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors.
    Horwich A; Dearnaley DP; Nicholls J; Jay G; Mason M; Harland S; Peckham MJ; Hendry WF
    J Clin Oncol; 1991 Jan; 9(1):62-9. PubMed ID: 1702147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors.
    Heideman RL; Kovnar EH; Kellie SJ; Douglass EC; Gajjar AJ; Walter AW; Langston JA; Jenkins JJ; Li Y; Greenwald C
    J Clin Oncol; 1995 Sep; 13(9):2247-54. PubMed ID: 7666082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience.
    Hara I; Miyake H; Yamada Y; Yamanaka K; Furukawa J; Kumano M; Takenaka A; Fujisawa M
    Anticancer Drugs; 2006 Oct; 17(9):1057-66. PubMed ID: 17001179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celiac trunk thrombosis and splenic infarction during chemotherapy for a testicular germ cell tumor.
    Verdonk RC; Rutgers B; Hospers GA
    Urology; 2008 Apr; 71(4):602. PubMed ID: 18295315
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapy of refractory germ cell cancer with Etoposide.
    Lederman GS; Garnick MB; Canellos GP; Richie JP
    J Clin Oncol; 1983 Nov; 1(11):706-9. PubMed ID: 6321675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome.
    Beyer J; Rick O; Weinknecht S; Kingreen D; Lenz K; Siegert W
    Bone Marrow Transplant; 1997 Nov; 20(10):813-9. PubMed ID: 9404920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.